INT335846

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.02
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 5
Disease Relevance 6.77
Pain Relevance 1.97

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

RNA binding (Snrpc) nucleus (Snrpc)
Anatomy Link Frequency
macrophages 2
B lymphocytes 2
Snrpc (Mus musculus)
Pain Link Frequency Relevance Heat
agonist 35 97.36 Very High Very High Very High
Inflammation 245 89.80 High High
chemokine 30 87.80 High High
cytokine 170 87.40 High High
tolerance 30 5.00 Very Low Very Low Very Low
ketamine 5 5.00 Very Low Very Low Very Low
anesthesia 5 5.00 Very Low Very Low Very Low
Inflammatory mediators 5 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Diabetes Mellitus 625 99.16 Very High Very High Very High
Sprains And Strains 15 91.96 High High
Apoptosis 75 90.36 High High
INFLAMMATION 245 89.80 High High
Congenital Anomalies 5 78.72 Quite High
Genetic Predisposition To Disease 5 75.60 Quite High
Death 110 54.88 Quite High
Increased Venous Pressure Under Development 10 46.80 Quite Low
Stress 45 33.28 Quite Low
Toxicity 25 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Therefore, we first examined whether agonist-stimulated T and B lymphocytes and macrophages derived from autoimmune diabetes-prone NOD mice are suppressed by targeting nuclear import with cell-penetrating cSN50 peptide (Fig. 1).
Localization (import) of cSN50 in macrophages associated with diabetes mellitus and agonist
1) Confidence 0.02 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2950856 Disease Relevance 1.66 Pain Relevance 0.49
Therefore, we first examined whether agonist-stimulated T and B lymphocytes and macrophages derived from autoimmune diabetes-prone NOD mice are suppressed by targeting nuclear import with cell-penetrating cSN50 peptide (Fig. 1).
Localization (import) of cSN50 in macrophages associated with diabetes mellitus and agonist
2) Confidence 0.02 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2950856 Disease Relevance 1.66 Pain Relevance 0.49
Synthesis, purification, and labeling of a cell-penetrating peptide inhibitor of nuclear import (cSN50) and its non-cell-penetrating control (cN50)
Localization (import) of cSN50
3) Confidence 0.02 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2950856 Disease Relevance 0.13 Pain Relevance 0
Therefore, we first examined whether agonist-stimulated T and B lymphocytes and macrophages derived from autoimmune diabetes-prone NOD mice are suppressed by targeting nuclear import with cell-penetrating cSN50 peptide (Fig. 1).
Localization (import) of cSN50 in B lymphocytes associated with diabetes mellitus and agonist
4) Confidence 0.01 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2950856 Disease Relevance 1.66 Pain Relevance 0.49
Therefore, we first examined whether agonist-stimulated T and B lymphocytes and macrophages derived from autoimmune diabetes-prone NOD mice are suppressed by targeting nuclear import with cell-penetrating cSN50 peptide (Fig. 1).
Localization (import) of cSN50 in B lymphocytes associated with diabetes mellitus and agonist
5) Confidence 0.01 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2950856 Disease Relevance 1.66 Pain Relevance 0.49

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox